I’m a little confused here. If the patent cliff was/is 2028 it’s my understanding that the options are to apply to the FDA and then if granted then go to the patents office and apply to them for an extension, objections can come in from 3rd parties during such time, this makes sense to me.
Acadia appears to have objected to MSN manufacturing after 2028 which they probably have a right to do at the moment, I think in this case Acadia have made the error so more bad them; please correct me if I’m wrong.
Acadia, page-602
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.625(3.02%) |
Mkt cap ! $2.570B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $20.02 | $1.242M | 61.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $20.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.10 | 197 | 5 |
View Market Depth
| Last trade - 11.24am 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |